Abstract
ObjectiveThis study aimed to review effectiveness studies comparing two biological anti-tumour necrosis factor agents, adalimumab (ADA) and infliximab (IFX), in the management of autoimmune uveitis.MethodsA systematic search was conducted across...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have